Addex Therapeutics (ADXN) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$2.0 million.
- Addex Therapeutics' Profit After Tax fell 1182.67% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1638.2 billion, marking a year-over-year increase of 5368.24%. This contributed to the annual value of $8.0 million for FY2024, which is 16823.63% up from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' Profit After Tax is -$2.0 million, which was down 1182.67% from -$2.4 million recorded in Q2 2025.
- Addex Therapeutics' Profit After Tax's 5-year high stood at -$579883.9 during Q2 2023, with a 5-year trough of -$3536.9 billion in Q1 2024.
- For the 4-year period, Addex Therapeutics' Profit After Tax averaged around -$345.0 billion, with its median value being -$2.8 million (2023).
- Its Profit After Tax has fluctuated over the past 5 years, first soared by 9226.59% in 2023, then crashed by 13590096289.68% in 2024.
- Quarter analysis of 4 years shows Addex Therapeutics' Profit After Tax stood at -$21.6 million in 2022, then surged by 86.95% to -$2.8 million in 2023, then plummeted by 98.83% to -$5.6 million in 2024, then soared by 64.82% to -$2.0 million in 2025.
- Its last three reported values are -$2.0 million in Q3 2025, -$2.4 million for Q2 2025, and -$1638.2 billion during Q1 2025.